Taro Fukao

R&d
Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.

Journal: Blood cancer journal

Published: June 05, 2024

Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma: Long-term outcomes in the Phase 3 IKEMA study.

Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma: Long-term outcomes in the Phase 3 IKEMA study.

Journal: Hematological oncology

Published: September 19, 2023

Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma.

Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma.

Journal: Cancer medicine

Published: August 04, 2023

Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies.

Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies.

Journal: Expert review of hematology

Published: September 23, 2021

Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer.

Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer.

Journal: BMC cancer

Published: September 02, 2021

Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.

Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.

Journal: Transfusion

Published: August 20, 2021

Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study.

Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study.

Journal: Investigational new drugs

Published: September 28, 2016

CNOT3 contributes to early B cell development by controlling Igh rearrangement and p53 mRNA stability.

CNOT3 contributes to early B cell development by controlling Igh rearrangement and p53 mRNA stability.

Journal: The Journal of experimental medicine

Published: March 03, 2015

Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer.

Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer.

Journal: RNA biology

Published: December 09, 2014

MicroRNA-132/212 family enhances arteriogenesis after hindlimb ischaemia through modulation of the Ras-MAPK pathway.

MicroRNA-132/212 family enhances arteriogenesis after hindlimb ischaemia through modulation of the Ras-MAPK pathway.

Journal: Journal of cellular and molecular medicine

Published: November 26, 2014

miR-212 and miR-132 are dispensable for mouse mammary gland development.

miR-212 and miR-132 are dispensable for mouse mammary gland development.

Journal: Nature genetics

Published: July 30, 2014

Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection.

Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection.

Journal: Nature communications

Published: April 29, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026